Allstate Corporation (ALL)
NYSE: ALL
· Real-Time Price · USD
206.38
-0.41 (-0.20%)
At close: Jun 05, 2025, 3:59 PM
208.75
1.15%
After-hours: Jun 05, 2025, 07:21 PM EDT
Allstate Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 | Dec 30, 2018 | Dec 30, 2017 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allstate Health And Benefits Revenue | 2.54B | 2.77B | 2.49B | 2.36B | 1.92B | 1.65B | 1.32B | 993M | 30.31B | 28.93B | 27.62B | 26.74B | 25.94B | 25.95B |
Allstate Health And Benefits Revenue Growth | -8.47% | +11.50% | +5.34% | +22.84% | +16.56% | +25.11% | +32.73% | -96.72% | +4.77% | +4.75% | +3.30% | +3.06% | -0.05% | n/a |
Property Liability Revenue | 58.34B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Property Liability Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Protection Services Revenue | 3.22B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Protection Services Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Allstate Protection Revenue | 53.87B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Allstate Protection Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 | Dec 30, 2018 | Dec 30, 2017 | Dec 30, 2016 |
---|---|---|---|---|---|---|---|---|
United States Revenue | 54.69B | 49.21B | 48.5B | 43.03B | 43.21B | 38.55B | 37.38B | 35.47B |
United States Revenue Growth | +11.12% | +1.48% | +12.69% | -0.41% | +12.08% | +3.14% | +5.37% | n/a |
Non-United States Revenue | 2.06B | 1.94B | 1.86B | 1.57B | 1.37B | 1.2B | 1.11B | 1.06B |
Non-United States Revenue Growth | +6.19% | +4.30% | +18.47% | +14.60% | +14.17% | +8.11% | +4.72% | n/a |
European Union Revenue | 346M | 258M | 232M | 188M | 95M | 61M | 35M | n/a |
European Union Revenue Growth | +34.11% | +11.21% | +23.40% | +97.89% | +55.74% | +74.29% | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 78M | -52M | 26M | -9M | -2M | -47M | 149M | -40M | -53M | 25M | 79M | 259M | -247M | -240M | 40M | -134M | -310M | -371M | -71M | 73M | 318M | -251M | 225M | 125M | 15M | 1.57B | -39M | -7M | 14M | 1.26B | 1.45B | 1.31B | 1.31B | 1.06B | 1.02B | 1.04B | 982M | 938M | 992M | 1.06B | 1.09B |
Selling, General, and Administrative Revenue Growth | -250.00% | -300.00% | -388.89% | +350.00% | -95.74% | -131.54% | -472.50% | -24.53% | -312.00% | -68.35% | -69.50% | -204.86% | +2.92% | -700.00% | -129.85% | -56.77% | -16.44% | +422.54% | -197.26% | -77.04% | -226.69% | -211.56% | +80.00% | +733.33% | -99.05% | -4133.33% | +457.14% | -150.00% | -98.89% | -13.07% | +10.21% | +0.38% | +22.95% | +4.11% | -1.83% | +5.91% | +4.69% | -5.44% | -6.50% | -2.66% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |